BioSpace News Archive

The Chemours Company, a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, announced that the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the company’s common stock for the second quarter of 2022.

Dante Labs, a global leader in genomics and precision medicine, is pleased to announce the company has been selected as the genetic testing provider for Abu Dhabi Stem Cells Center, the Abu Dhabi-based specialist healthcare center focused on cell therapy and regenerative medicine.